针对非小细胞肺癌的吸入药物
Arwa Omar Al Khatib1,2, Mohamed El-Tanani2,3, Hisham Al-Obaidi1
1School of Pharmacy, University of Reading, Reading RG6 6AD, UK.
Pharmaceutics
|December 23, 2023
概括
肺部直接输送药物提供了精确的癌症治疗,副作用比口服或肠道方法少. 本综述探讨了非小细胞肺癌 (NSCLC) 的吸入疗法,包括纳米粒子和组合疗法.
科学领域:
- 肺部药物输送 肺部药物输送
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- 传统的肺癌治疗方法 (口服,腹腔) 有显著的全身副作用.
- 直接输送药物到肺部可以提高准确性,减少不良事件.
- 呼吸道的复杂性给吸入疗法带来了挑战.
研究的目的:
- 审查肺癌的直接肺药物输送策略,重点关注非小细胞肺癌 (NSCLC).
- 探索使用纳米粒子和脂质载体的积极和被动准技术.
- 研究将吸入疗法与化疗和免疫疗法结合使用的协同效应潜力.
主要方法:
- 对肺部药物输送系统的现有文献的审查.
- 对NSCLC的积极和被动准策略的分析.
- 探索涉及吸入,化疗和免疫疗法的组合疗法.
主要成果:
- 直接的肺部输送可以最大限度地减少与传统癌症治疗相关的全身毒性.
- 纳米颗粒和脂质载体在向性肺癌治疗方面表现有前途.
- 组合策略可能会提高治疗疗效和患者的治疗结果.
结论:
- 直接输送肺部药物是一种有前途的方法,可以改善肺癌的治疗,特别是NSCLC.
- 先进的输送系统和组合疗法具有优化患者护理的潜力.
- 需要进一步的研究来克服吸入药物输送系统的挑战.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhaled Medications
276
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
276
Drugs Used in Lower Respiratory Disorders: Overview
449
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
449
Antiasthma Drugs: Leukotriene Modifiers
315
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
315
Drug Delivery: Miscellaneous Routes
345
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
345
Antiasthma Drugs: β2-Adrenoceptor Agonists
271
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
271


